Clinical Trial Update: PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia [Phase 1]

View source ↗

Summary

A Phase 1 PET imaging trial evaluating α7 and α4β2-nAChR in schizophrenia was terminated; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Schizophrenia | Phase 1 | Status: TERMINATED